Why stopping drug use before conception matters for sperm, eggs, and reproductive outcomes
Recreational drug use is a significant yet often under-recognised contributor to subfertility. Substances commonly perceived as “occasional” or “low risk”, including cannabis, cocaine, MDMA, amphetamines, and opioids, have been shown to impair reproductive hormones, gamete quality, and pregnancy outcomes in both men and women.
Crucially, these effects often occur prior to conception, during the critical months of sperm development and egg maturation. As with alcohol, reproductive harm may already be established before pregnancy is achieved.
This summarises the evidence on recreational drug use and fertility, with practical implications for preconception care.
Effects of Recreational Drugs on Sperm Health
Cannabis (THC)
Cannabis is the most extensively studied recreational drug in relation to male fertility. Δ9-tetrahydrocannabinol (THC) binds to cannabinoid receptors (CB1 and CB2) expressed throughout the hypothalamic–pituitary–gonadal axis and within the testes themselves (du Plessis et al., 2015).
Documented effects include:
- Reduced sperm concentration
- Reduced motility
- Abnormal morphology
- Increased sperm DNA fragmentation
- Altered epigenetic signalling in sperm
A systematic review and meta-analysis by Gundersen et al. (2015) demonstrated significantly lower sperm concentration and total sperm count among cannabis users compared with non-users. More recent studies suggest that regular use (≥1–2 times per week) is sufficient to produce measurable changes in semen parameters (Nassan et al., 2019).
Epigenetic concerns:
Emerging evidence indicates that cannabis alters sperm DNA methylation patterns, with some changes persisting after cessation and potentially influencing offspring development (Murphy et al., 2018).
Cocaine, MDMA, and Amphetamines
Stimulant drugs exert direct gonadotoxic effects and disrupt central neuroendocrine regulation.
Observed effects include:
- Suppression of testosterone
- Impaired spermatogenesis
- Increased oxidative stress
- Increased sperm DNA damage
Animal and human data indicate that cocaine and amphetamines impair Sertoli cell function and reduce sperm viability (França et al., 2020). MDMA (ecstasy) has been associated with oxidative damage and mitochondrial dysfunction within sperm cells, compromising motility and fertilisation capacity (Dias et al., 2019).
Opioids (including non-medical use)
Opioids suppress gonadotropin-releasing hormone (GnRH), leading to secondary hypogonadism.
Effects include:
- Reduced testosterone production
- Decreased sperm count
- Reduced libido and erectile function
Chronic opioid exposure has been consistently associated with impaired spermatogenesis and poor semen quality (Vuong et al., 2010).
Effects of Recreational Drugs on Egg Quality and Female Fertility
Female fertility appears highly sensitive to recreational drug exposure, particularly during follicular development and ovulation.
Cannabis
Cannabis use in women has been associated with:
- Disrupted ovulation
- Luteal phase abnormalities
- Altered estrogen and progesterone signalling
- Increased anovulatory cycles
A prospective cohort study by Wise et al. (2018) demonstrated reduced fecundability among women using cannabis while attempting conception. In assisted reproduction settings, cannabis use has been linked to fewer retrieved oocytes and poorer embryo quality (Klonoff-Cohen et al., 2006).
Stimulants and Party Drugs
Cocaine and amphetamines impair ovarian blood flow, increase oxidative stress within follicles, and disrupt hypothalamic–pituitary signalling.
Observed outcomes include:
- Menstrual irregularity
- Increased risk of anovulation
- Reduced implantation rates
MDMA exposure has been associated with neuroendocrine dysregulation and altered prolactin and cortisol levels, indirectly impairing reproductive hormone balance (Parrott, 2013).
Opioids
Opioid use in women is associated with:
- Amenorrhoea or oligomenorrhoea
- Suppressed ovulation
- Reduced estradiol production
These effects may persist beyond cessation, particularly with prolonged use (Vuong et al., 2010).
Assisted Reproductive Outcomes
Recreational drug use adversely affects outcomes in assisted reproduction.
Studies have demonstrated:
- Reduced implantation rates
- Increased miscarriage risk
- Reduced live birth rates
In IVF populations, cannabis use has been associated with lower pregnancy and live birth rates, particularly when both partners use concurrently (Klonoff-Cohen et al., 2006).
Is There a “Safe” Level of Recreational Drug Use?
Current evidence does not support a safe threshold for recreational drug use during the preconception period.
Key points:
- Effects are often dose-dependent but non-linear
- “Occasional” use may still coincide with critical windows of gamete development
- Combined exposures (e.g. alcohol + cannabis) amplify reproductive harm
Given that:
- Spermatogenesis takes ~74 days
- Folliculogenesis spans months to years
drug exposure during these windows may affect reproductive potential well before conception occurs.
Recreational Drugs and Fertility Effects
| Substance | Observed fertility effects | Key evidence |
| Cannabis | ↓ sperm count & motility, ↓ fecundability, epigenetic changes | Gundersen et al., 2015; Nassan et al., 2019 |
| Cocaine | Hormonal suppression, sperm DNA damage | França et al., 2020 |
| MDMA | Oxidative sperm damage, endocrine disruption | Dias et al., 2019 |
| Amphetamines | ↓ testosterone, impaired spermatogenesis | França et al., 2020 |
| Opioids | Hypogonadism, amenorrhoea, ↓ sperm production | Vuong et al., 2010 |
Can Fertility Recover After Stopping Drug Use?
Recovery is possible, but incomplete in some cases.
- Men: Semen parameters may improve within 2–4 months after cessation, depending on substance, duration, and baseline health.
- Women: Hormonal recovery may occur within several cycles, but cumulative ovarian damage and age-related decline limit reversibility.
- Epigenetic effects: Some sperm DNA methylation changes may persist beyond cessation, raising concern for transgenerational effects (Murphy et al., 2018).
Earlier cessation confers greater benefit.
Briefly… the Chinese Medicine Perspective
In Chinese medicine, recreational drugs are considered toxic, dispersing, and Essence-depleting. Cannabis and stimulants disrupt the Shen and Liver Qi, while opioids and depressants damage Kidney Yang and Kidney Essence. Over time, this leads to depletion of Jing, impaired Blood production, and loss of harmonious communication between the Heart, Kidney, and Chong–Ren axis which directly undermines fertility. These traditional frameworks closely parallel biomedical findings related to endocrine disruption, oxidative stress, and impaired gametogenesis.
Key Messages
• Recreational drugs affect fertility before conception
• No recreational drug has been shown to be fertility-neutral
• Both partners’ exposure matters
• Gamete health reflects the preceding months of exposure
• Cessation is one of the most powerful preconception interventions available
If you’d like to find out more about how we can assist you with your fertility, check out this page or book in a discovery call.
References
Dias, T. R., Alves, M. G., Silva, B. M., Oliveira, P. F., & Silva, J. (2019). Recreational drug abuse and male fertility. Asian Journal of Andrology, 21(1), 1–10.
du Plessis, S. S., Agarwal, A., Syriac, A., & du Plessis, S. S. (2015). Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. Journal of Assisted Reproduction and Genetics, 32(11), 1575–1588.
França, L. R., Avelar, G. F., & Almeida, F. F. (2020). Impact of illicit drugs on male reproductive health. Reproduction, 159(5), R231–R247.
Gundersen, T. D., Jørgensen, N., Andersson, A.-M., Bang, A. K., Nordkap, L., Skakkebaek, N. E., & Jensen, T. K. (2015). Association between use of marijuana and male reproductive hormones and semen quality. Human Reproduction, 30(9), 1–10.
Klonoff-Cohen, H., Lam-Kruglick, P., & Gonzalez, C. (2006). Effects of maternal and paternal marijuana use on in vitro fertilization outcome. American Journal of Obstetrics and Gynecology, 194(2), 369–376.
Murphy, S. K., Itchon-Ramos, N., Visco, Z., Huang, Z., Grenier, C., Schrott, R., … Hoyo, C. (2018). Cannabinoid exposure and altered DNA methylation in human sperm. Epigenetics, 13(12), 1208–1221.
Nassan, F. L., Arvizu, M., Mínguez-Alarcón, L., Williams, P. L., Attaman, J., Petrozza, J., … Chavarro, J. E. (2019). Marijuana smoking and markers of testicular function among men from a fertility centre. Human Reproduction, 34(4), 715–723.
Parrott, A. C. (2013). Human psychobiology of MDMA or ‘ecstasy’: An overview of 25 years of empirical research. Human Psychopharmacology, 28(4), 289–307.
Vuong, C., Van Uum, S. H. M., O’Dell, L. E., Lutfy, K., & Friedman, T. C. (2010). The effects of opioids and opioid analogs on animal and human endocrine systems. Endocrine Reviews, 31(1), 98–132.
Wise, L. A., Wesselink, A. K., Hatch, E. E., Rothman, K. J., Mikkelsen, E. M., & Sorensen, H. T. (2018). Marijuana use and fecundability in a North American preconception cohort study. Journal of Epidemiology and Community Health, 72(3), 208–215.